Patent details

EP3926044 Title: PREPARATION OF FACTOR XA DERIVATIVES

Basic Information

Publication number:
EP3926044
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP211649231
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PREPARATION OF FACTOR XA DERIVATIVES
French Title of Invention:
PRÉPARATION DE DÉRIVÉS DU FACTEUR XA
German Title of Invention:
HERSTELLUNG VON FAKTOR-XA-DERIVATEN
SPC Number:

Dates

Filing date:
19/06/2017
Grant date:
04/06/2025
EP Publication Date:
22/12/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/06/2025
EP B1 Publication Date:
04/06/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/06/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/05/2025
 
 

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, Boston, MA 02210, United States (US)

Inventor

1

Name:
LU, Genmin
Address:
United States (US)

2

Name:
CONLEY, Pamela B.
Address:
United States (US)

3

Name:
KARBARZ, Mark
Address:
United States (US)

Priority

Priority Number:
201662351841 P
Priority Date:
17/06/2016
Priority Country:
United States (US)

Classification

IPC classification:
C12N 9/64; C07K 1/22;

Publication

European Patent Bulletin

Issue number:
202523
Publication date:
04/06/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages